Interview with André Bràzay, President, Sandoz Hungary
Taking a look at the voices of the pharmaceutical industry in Hungary, we see AIPM and MAYGOSZ as the 2 key associations. And while MAGYOSZ already represents many generic players……
Address: Bartók Béla út 43-47 H-1114 Budapest,Hungary
Tel: +36 1 430 28 90
Web: http://www.sandoz.hu/site/hu/index.shtml
The Sandoz Pty Ltd ‘s mission pillars, goals, aspirations, our values match, the international principles of Sandoz.
It is our fundamental duty is to our products, our activities improve our lives. To that end, patent medicines from leaving active gyógyszerösszetevőket, a wide range of biotechnology products developed, manufactured and sold at an affordable price, but meeting the highest standards of quality.
During our activities we have created a value system that gives all our partners, our customers continuously expect the highest standards of serving. The world’s leading generic manufacturer of the task we facilitate access to medical care, and health care systems támogatását.Tesszük all aware of the responsibility which the market maker requires.
The Sandoz social responsibility committed, so seek him, that of our long-term, sustainable, economic, social and environmental aspects.
The company’s philosophy of most of the high quality, global presence and innovation in threes we legtömörebben summarized.
The high quality standards by Sandoz in the ever-increasing customer demands are fully met aims itself.
A global presence provides Sandoz for a uniform, international business, as in other countries experienced positive trends, and immediately at the national market .
The innovation – paradoxically – Sandoznál tradition. Our product range is a continuous expansion of committed ourselves to ensuring that our clients always know the latest products and technologies provide.
The Sandoz Hungaria Ltd. we are committed to earn our unreserved confidence. To this end, the company’s global experience and innovative approach we use the best quality, unique products and services we provide. Our goal is to earn customer trust, and they regarded us as a generic drug manufacturers the most customer-oriented company of.
Sandoz Hungaria Ltd. continuously monitor our clients’ changing needs and strive to creativity and innovative approach to these needs as possible to able to answer.
Therapeutic Areas
Market-leading product portfolio (so-called ‘blockbuster’) and fill gaps in its niche market for both drugs include all major therapeutic areas, in particular:
Antibiotics
Cardiovascular
Central Nervous System
Stomach and digestive tract
Osteoporosis
Dermatology
Allergy
Oncology
Muscle and skeletal
Urology
Top 5 products containing active worldwide
Fentanyl
Omeprazole
Amoxicillin-clavulanate
Metoprolol
Simvastatin
Taking a look at the voices of the pharmaceutical industry in Hungary, we see AIPM and MAYGOSZ as the 2 key associations. And while MAGYOSZ already represents many generic players……
Anna Wienner, general manager of IBSA Hungary, gives an update on the recent activities and achievement of the affiliate since her previous interview in 2016. Furthermore, Wienner goes on to…
Norbert Langen, founder and CEO of Phytotec, a Hungarian distributor of evidence-based natural Rx and OTC drugs, introduces the company and its unique approach to marketing non-chemically formulated pharmaceuticals in…
Dr Ildikó Horvath, Hungary’s State Secretary for Health explains her role and shares insights on the key health trends in Hungary, the government’s top priority in improving healthcare, the importance…
Here we highlight five of the most important women working in healthcare and the life sciences in Central & Eastern Europe (CEE) today. From regulators to pharma affiliate heads with…
As the only one of Hungary’s four historical pharmaceutical manufactures to have resisted international acquisition, Gedeon Richter stands alone as the country’s national champion. However, the company does not exist…
Established in Hungary in 1913, Egis is a traditional Central Eastern European pharmaceutical company with an international footprint across the globe. As one of the four largest historical pharma companies…
Gábor Orbán, CEO of Gedeon Richter, highlights the recent turnaround of the company’s performance, its exciting new collaboration with Allergan in the US market, and the landmark launch of Gedeon’s…
Dr Péter Holchacker, director of the Hungarian Association of Innovative Pharmaceutical Manufacturers (AIPM), shares his insights on the key activities of the organisation, the collaborations it fosters with authorities and…
Attila Lukács, general manager Hungary, Romania, Bulgaria for CSL Behring outlines emergent trends in the Hungarian plasma medication market, how the affiliate has succeeded in becoming a partner to patient…
Laszlo Dinca, managing director of Vanessa Research – Hungary, shares his insights on the company’s rare and orphan disease portfolio; the intentions behind the acquisition of Hungaro-Gal Pharmaceutical Manufacturing [HG…
Irma Veberic, general manager of Roche Hungary, gives her insights on the key issues being faced by the Hungarian healthcare system and the company’s role as a partner in improving…
István Peták, co-founder and CEO of Oncompass introduces the innovative start-up and elaborates on how its solution for digital treatment planning and digital biomarkers can revolutionize not only personalized oncology…
See our Cookie Privacy Policy Here